- About Us
- Advertise
- Editorial
- Contact Us
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2026 MJH Life Sciences™ and Pharmaceutical Commerce - Biopharma Business News, Market Insights. All rights reserved.
Pharmaceutical Commerce - December 2025
Pharmaceutical Commerce: December 2025 Interactive Digital Edition
December 17, 2025
20
6
View the Pharmaceutical Commerce December 2025 issue in an interactive format.
The Market Access Terrain
December 17, 2025
20
6
Highlighting the December issue of Pharmaceutical Commerce is a dive into the evolving landscape of market access in pharmaceuticals, including AI's role and new pricing dynamics shaping the industry.
Finishing Strong While Looking Ahead
December 17, 2025
20
6
Next year's content looks to carry over the momentum here at Pharmaceutical Commerce.
The Key to Connecting with Patients: Pharma's Market Access Transformation
December 16, 2025
20
6
Traditional market access practices are being transformed by an increasingly rocky landscape of rebate, discount, and direct-distribution practices, but artificial intelligence may clear the pathways to profitability.
The Next Era of Drug Safety is in Intelligent Action
December 16, 2025
20
6
As safety data grows in scale and complexity, AI-powered pharmacovigilance is emerging as a strategic imperative—helping drugmakers improve detection, reduce risk, and strengthen commercial performance.
Why Specialty Drugs Dominate Spending, and the Frontline Roles Shaping Patient Access
December 16, 2025
20
6
CoverMyMeds’ Megan Wetzel unpacks the forces behind rising specialty spend, the real impact of access barriers, and how field reimbursement teams help providers guide patients through today’s fragmented system.
How AI Control Towers and Digital Twins Can Restore Pharmaceutical Profit Margins
December 15, 2025
20
6
AI-powered control towers and digital twins are emerging as essential tools to prevent costly supply chain failures and restore operational reliability.
Working with the Middle
December 15, 2025
20
6
How pharma can productively coexist with PBMs—and still lower drug costs faster.
The Great Repricing: How Pharma Must Evolve for Three Diverging Payer Economies
December 12, 2025
20
6
The fracturing of the US drug market’s traditional model is forcing a demand for a strategic bifurcation to maintain profitability, compliance, and patient access in the decade ahead.
The ROI Moment Pharma Keeps Missing: Point-of-Care as Revenue Protection
December 12, 2025
20
6
It’s not marketing—it's the activation layer for every dollar spent on patient access and support.
A 'Beautiful Fake': Pharma Fraudsters Upping Their Game
December 11, 2025
20
6
Counterfeit pharma networks are becoming more sophisticated—leveraging advanced packaging, fragmented logistics, and global trade gaps—making detection harder and patient risk greater than ever.
Americans Call on Policymakers to Prioritize Healthcare Access and Affordability
December 11, 2025
20
6
Rising prescription costs and premiums are forcing more than half of patients to take drastic measures to cover OOP costs.
The Longer-Term Impact of MFN Pricing
December 11, 2025
20
6
Various agreements with the Trump administration could have long-term ramifications for Medicaid access and global pricing strategy.
From Data Overload to Intelligent Commercialization: How Pharma Can Turn Connection Into Competitive Advantage
November 21, 2025
20
6
When intelligence flows across clinical, access, and engagement channels, commercialization shifts from reactive to predictive, giving teams the real-time edge to win in a fast-moving market.